▶ 調査レポート

ナノドラッグの世界市場 2020年:企業別・地域別・種類別・用途別市場予測

• 英文タイトル:Global Nano-drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Global Nano-drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025「ナノドラッグの世界市場 2020年:企業別・地域別・種類別・用途別市場予測」(市場規模、市場予測)調査レポートです。• レポートコード:D0804-08827
• 出版社/出版日:GlobalInfoResearch / 2020年7月28日
• レポート形態:英文、PDF、130ページ
• 納品方法:Eメール
• 産業分類:医薬品・治療
• 販売価格(消費税別)
  Single User¥372,360 (USD3,480)▷ お問い合わせ
  Multi User¥558,540 (USD5,220)▷ お問い合わせ
  Corporate User¥744,720 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ナノドラッグの世界市場を広く調査・分析し、今後の市場展望をまとめております。ナノドラッグの種類別市場規模(リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションとナノエマルション、ナノサスペンション)、用途別市場規模(がん・腫瘍、自己免疫疾患)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Merck、Eli Lilly、Abbott、Pfizer、Sanofi、Novartis、Johnson & Johnson、Roche、GlaxoSmithKline、Astrazeneca、OSI Pharmaceuticals、Mitsubishi Pharma、Celgene、Selecta Biosciences、Kadmon Pharmaceuticals、Gilead Sciences、Novavax、Kaken Pharmaceutical、Samyang Biopharm、Stryker、Par Pharmaceutical、Lummy、Cerulean Pharma、Navidea Biopharmaceuticals
・地域別グローバル市場分析 2015年-2020年
・ナノドラッグの北米市場(アメリカ、カナダ、メキシコ)
・ナノドラッグのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ナノドラッグのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ナノドラッグの南米市場(ブラジル、アルゼンチン)
・ナノドラッグの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションとナノエマルション、ナノサスペンション
・用途別分析:がん・腫瘍、自己免疫疾患
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Nano-drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Nano-drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nano-drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nano-drug market has been segmented into
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension

By Application, Nano-drug has been segmented into:
Cancer and Tumors
Autoimmune Disorders

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nano-drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Nano-drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nano-drug market.

The report offers in-depth assessment of the growth and other aspects of the Nano-drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Nano-drug Market Share Analysis
Nano-drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nano-drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nano-drug sales, revenue and market share for each player covered in this report.

The major players covered in Nano-drug are:
Merck
Eli Lilly
Abbott
Pfizer
Sanofi
Novartis
Johnson & Johnson
Roche
GlaxoSmithKline
Astrazeneca
OSI Pharmaceuticals
Mitsubishi Pharma
Celgene
Selecta Biosciences
Kadmon Pharmaceuticals
Gilead Sciences
Novavax
Kaken Pharmaceutical
Samyang Biopharm
Stryker
Par Pharmaceutical
Lummy
Cerulean Pharma
Navidea Biopharmaceuticals

Among other players domestic and global, Nano-drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nano-drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nano-drug, with price, sales, revenue and global market share of Nano-drug in 2018 and 2019.
Chapter 3, the Nano-drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nano-drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nano-drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nano-drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Nano-drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nano-drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Market Analysis by Application
1.3.1 Overview: Global Nano-drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Overview of Global Nano-drug Market
1.4.1 Global Nano-drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche SWOT Analysis
2.8.4 Roche Product and Services
2.8.5 Roche Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Astrazeneca
2.10.1 Astrazeneca Details
2.10.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Astrazeneca SWOT Analysis
2.10.4 Astrazeneca Product and Services
2.10.5 Astrazeneca Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 OSI Pharmaceuticals
2.11.1 OSI Pharmaceuticals Details
2.11.2 OSI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 OSI Pharmaceuticals SWOT Analysis
2.11.4 OSI Pharmaceuticals Product and Services
2.11.5 OSI Pharmaceuticals Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mitsubishi Pharma
2.12.1 Mitsubishi Pharma Details
2.12.2 Mitsubishi Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Mitsubishi Pharma SWOT Analysis
2.12.4 Mitsubishi Pharma Product and Services
2.12.5 Mitsubishi Pharma Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Celgene
2.13.1 Celgene Details
2.13.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Celgene SWOT Analysis
2.13.4 Celgene Product and Services
2.13.5 Celgene Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Selecta Biosciences
2.14.1 Selecta Biosciences Details
2.14.2 Selecta Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Selecta Biosciences SWOT Analysis
2.14.4 Selecta Biosciences Product and Services
2.14.5 Selecta Biosciences Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Kadmon Pharmaceuticals
2.15.1 Kadmon Pharmaceuticals Details
2.15.2 Kadmon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Kadmon Pharmaceuticals SWOT Analysis
2.15.4 Kadmon Pharmaceuticals Product and Services
2.15.5 Kadmon Pharmaceuticals Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Gilead Sciences
2.16.1 Gilead Sciences Details
2.16.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Gilead Sciences SWOT Analysis
2.16.4 Gilead Sciences Product and Services
2.16.5 Gilead Sciences Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Novavax
2.17.1 Novavax Details
2.17.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Novavax SWOT Analysis
2.17.4 Novavax Product and Services
2.17.5 Novavax Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Kaken Pharmaceutical
2.18.1 Kaken Pharmaceutical Details
2.18.2 Kaken Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Kaken Pharmaceutical SWOT Analysis
2.18.4 Kaken Pharmaceutical Product and Services
2.18.5 Kaken Pharmaceutical Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Samyang Biopharm
2.19.1 Samyang Biopharm Details
2.19.2 Samyang Biopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Samyang Biopharm SWOT Analysis
2.19.4 Samyang Biopharm Product and Services
2.19.5 Samyang Biopharm Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Stryker
2.20.1 Stryker Details
2.20.2 Stryker Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Stryker SWOT Analysis
2.20.4 Stryker Product and Services
2.20.5 Stryker Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Par Pharmaceutical
2.21.1 Par Pharmaceutical Details
2.21.2 Par Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Par Pharmaceutical SWOT Analysis
2.21.4 Par Pharmaceutical Product and Services
2.21.5 Par Pharmaceutical Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Lummy
2.22.1 Lummy Details
2.22.2 Lummy Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Lummy SWOT Analysis
2.22.4 Lummy Product and Services
2.22.5 Lummy Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 Cerulean Pharma
2.23.1 Cerulean Pharma Details
2.23.2 Cerulean Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Cerulean Pharma SWOT Analysis
2.23.4 Cerulean Pharma Product and Services
2.23.5 Cerulean Pharma Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.24 Navidea Biopharmaceuticals
2.24.1 Navidea Biopharmaceuticals Details
2.24.2 Navidea Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Navidea Biopharmaceuticals SWOT Analysis
2.24.4 Navidea Biopharmaceuticals Product and Services
2.24.5 Navidea Biopharmaceuticals Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nano-drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nano-drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nano-drug Manufacturer Market Share in 2019
3.3.2 Top 6 Nano-drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nano-drug Sales, Revenue and Market Share by Regions
4.1.1 Global Nano-drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nano-drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Nano-drug Sales and Growth Rate (2015-2020)
4.3 Europe Nano-drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nano-drug Sales and Growth Rate (2015-2020)
4.5 South America Nano-drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nano-drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nano-drug Sales, Revenue and Market Share by Country
5.1.1 North America Nano-drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Nano-drug Revenue and Market Share by Country (2015-2020)
5.2 United States Nano-drug Sales and Growth Rate (2015-2020)
5.3 Canada Nano-drug Sales and Growth Rate (2015-2020)
5.4 Mexico Nano-drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nano-drug Sales, Revenue and Market Share by Country
6.1.1 Europe Nano-drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nano-drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Nano-drug Sales and Growth Rate (2015-2020)
6.3 UK Nano-drug Sales and Growth Rate (2015-2020)
6.4 France Nano-drug Sales and Growth Rate (2015-2020)
6.5 Russia Nano-drug Sales and Growth Rate (2015-2020)
6.6 Italy Nano-drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nano-drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nano-drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nano-drug Revenue and Market Share by Regions (2015-2020)
7.2 China Nano-drug Sales and Growth Rate (2015-2020)
7.3 Japan Nano-drug Sales and Growth Rate (2015-2020)
7.4 Korea Nano-drug Sales and Growth Rate (2015-2020)
7.5 India Nano-drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nano-drug Sales and Growth Rate (2015-2020)
7.7 Australia Nano-drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nano-drug Sales, Revenue and Market Share by Country
8.1.1 South America Nano-drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Nano-drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nano-drug Sales and Growth Rate (2015-2020)
8.3 Argentina Nano-drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nano-drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nano-drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nano-drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nano-drug Sales and Growth Rate (2015-2020)
9.3 Turkey Nano-drug Sales and Growth Rate (2015-2020)
9.4 Egypt Nano-drug Sales and Growth Rate (2015-2020)
9.5 South Africa Nano-drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nano-drug Sales and Market Share by Type (2015-2020)
10.2 Global Nano-drug Revenue and Market Share by Type (2015-2020)
10.3 Global Nano-drug Price by Type (2015-2020)
11 Global Nano-drug Market Segment by Application
11.1 Global Nano-drug Sales Market Share by Application (2015-2020)
11.2 Global Nano-drug Revenue Market Share by Application (2015-2020)
11.3 Global Nano-drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nano-drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Nano-drug Market Forecast by Regions (2021-2025)
12.2.1 North America Nano-drug Market Forecast (2021-2025)
12.2.2 Europe Nano-drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nano-drug Market Forecast (2021-2025)
12.2.4 South America Nano-drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nano-drug Market Forecast (2021-2025)
12.3 Nano-drug Market Forecast by Type (2021-2025)
12.3.1 Global Nano-drug Sales Forecast by Type (2021-2025)
12.3.2 Global Nano-drug Market Share Forecast by Type (2021-2025)
12.4 Nano-drug Market Forecast by Application (2021-2025)
12.4.1 Global Nano-drug Sales Forecast by Application (2021-2025)
12.4.2 Global Nano-drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Nano-drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nano-drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nano-drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Nano-drug Major Business
Table 9. Merck Nano-drug Total Revenue (USD Million) (2018-2019)
Table 10. Merck SWOT Analysis
Table 11. Merck Nano-drug Product and Services
Table 12. Merck Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly Nano-drug Major Business
Table 15. Eli Lilly Nano-drug Total Revenue (USD Million) (2018-2019)
Table 16. Eli Lilly SWOT Analysis
Table 17. Eli Lilly Nano-drug Product and Services
Table 18. Eli Lilly Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Abbott Basic Information, Manufacturing Base and Competitors
Table 20. Abbott Nano-drug Major Business
Table 21. Abbott Nano-drug Total Revenue (USD Million) (2018-2019)
Table 22. Abbott SWOT Analysis
Table 23. Abbott Nano-drug Product and Services
Table 24. Abbott Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Nano-drug Major Business
Table 27. Pfizer Nano-drug Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Nano-drug Product and Services
Table 30. Pfizer Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Nano-drug Major Business
Table 33. Sanofi Nano-drug Total Revenue (USD Million) (2018-2019)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi Nano-drug Product and Services
Table 36. Sanofi Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Nano-drug Major Business
Table 39. Novartis Nano-drug Total Revenue (USD Million) (2018-2019)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Nano-drug Product and Services
Table 42. Novartis Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Nano-drug Major Business
Table 45. Johnson & Johnson Nano-drug Total Revenue (USD Million) (2018-2019)
Table 46. Johnson & Johnson SWOT Analysis
Table 47. Johnson & Johnson Nano-drug Product and Services
Table 48. Johnson & Johnson Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Roche Basic Information, Manufacturing Base and Competitors
Table 50. Roche Nano-drug Major Business
Table 51. Roche Nano-drug Total Revenue (USD Million) (2018-2019)
Table 52. Roche SWOT Analysis
Table 53. Roche Nano-drug Product and Services
Table 54. Roche Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Nano-drug Major Business
Table 57. GlaxoSmithKline Nano-drug Total Revenue (USD Million) (2018-2019)
Table 58. GlaxoSmithKline SWOT Analysis
Table 59. GlaxoSmithKline Nano-drug Product and Services
Table 60. GlaxoSmithKline Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 62. Astrazeneca Nano-drug Major Business
Table 63. Astrazeneca Nano-drug Total Revenue (USD Million) (2018-2019)
Table 64. Astrazeneca SWOT Analysis
Table 65. Astrazeneca Nano-drug Product and Services
Table 66. Astrazeneca Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. OSI Pharmaceuticals Nano-drug Major Business
Table 69. OSI Pharmaceuticals Nano-drug Total Revenue (USD Million) (2018-2019)
Table 70. OSI Pharmaceuticals SWOT Analysis
Table 71. OSI Pharmaceuticals Nano-drug Product and Services
Table 72. OSI Pharmaceuticals Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Mitsubishi Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Mitsubishi Pharma Nano-drug Major Business
Table 75. Mitsubishi Pharma Nano-drug Total Revenue (USD Million) (2018-2019)
Table 76. Mitsubishi Pharma SWOT Analysis
Table 77. Mitsubishi Pharma Nano-drug Product and Services
Table 78. Mitsubishi Pharma Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Celgene Basic Information, Manufacturing Base and Competitors
Table 80. Celgene Nano-drug Major Business
Table 81. Celgene Nano-drug Total Revenue (USD Million) (2018-2019)
Table 82. Celgene SWOT Analysis
Table 83. Celgene Nano-drug Product and Services
Table 84. Celgene Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Selecta Biosciences Basic Information, Manufacturing Base and Competitors
Table 86. Selecta Biosciences Nano-drug Major Business
Table 87. Selecta Biosciences Nano-drug Total Revenue (USD Million) (2018-2019)
Table 88. Selecta Biosciences SWOT Analysis
Table 89. Selecta Biosciences Nano-drug Product and Services
Table 90. Selecta Biosciences Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Kadmon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Kadmon Pharmaceuticals Nano-drug Major Business
Table 93. Kadmon Pharmaceuticals Nano-drug Total Revenue (USD Million) (2018-2019)
Table 94. Kadmon Pharmaceuticals SWOT Analysis
Table 95. Kadmon Pharmaceuticals Nano-drug Product and Services
Table 96. Kadmon Pharmaceuticals Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 98. Gilead Sciences Nano-drug Major Business
Table 99. Gilead Sciences Nano-drug Total Revenue (USD Million) (2018-2019)
Table 100. Gilead Sciences SWOT Analysis
Table 101. Gilead Sciences Nano-drug Product and Services
Table 102. Gilead Sciences Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Novavax Basic Information, Manufacturing Base and Competitors
Table 104. Novavax Nano-drug Major Business
Table 105. Novavax Nano-drug Total Revenue (USD Million) (2018-2019)
Table 106. Novavax SWOT Analysis
Table 107. Novavax Nano-drug Product and Services
Table 108. Novavax Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Kaken Pharmaceutical Nano-drug Type and Application
Table 110. Kaken Pharmaceutical Nano-drug Major Business
Table 111. Kaken Pharmaceutical Nano-drug Total Revenue (USD Million) (2018-2019)
Table 112. Kaken Pharmaceutical SWOT Analysis
Table 113. Kaken Pharmaceutical Nano-drug Product and Services
Table 114. Kaken Pharmaceutical Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Samyang Biopharm Basic Information, Manufacturing Base and Competitors
Table 116. Samyang Biopharm Nano-drug Major Business
Table 117. Samyang Biopharm Nano-drug Total Revenue (USD Million) (2018-2019)
Table 118. Samyang Biopharm SWOT Analysis
Table 119. Samyang Biopharm Nano-drug Product and Services
Table 120. Samyang Biopharm Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Stryker Basic Information, Manufacturing Base and Competitors
Table 122. Stryker Nano-drug Major Business
Table 123. Stryker Nano-drug Total Revenue (USD Million) (2018-2019)
Table 124. Stryker SWOT Analysis
Table 125. Stryker Nano-drug Product and Services
Table 126. Stryker Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Par Pharmaceutical Nano-drug Major Business
Table 129. Par Pharmaceutical Nano-drug Total Revenue (USD Million) (2018-2019)
Table 130. Par Pharmaceutical SWOT Analysis
Table 131. Par Pharmaceutical Nano-drug Product and Services
Table 132. Par Pharmaceutical Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Lummy Basic Information, Manufacturing Base and Competitors
Table 134. Lummy Nano-drug Major Business
Table 135. Lummy Nano-drug Total Revenue (USD Million) (2018-2019)
Table 136. Lummy SWOT Analysis
Table 137. Lummy Nano-drug Product and Services
Table 138. Lummy Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 139. Cerulean Pharma Basic Information, Manufacturing Base and Competitors
Table 140. Cerulean Pharma Nano-drug Major Business
Table 141. Cerulean Pharma Nano-drug Total Revenue (USD Million) (2018-2019)
Table 142. Cerulean Pharma SWOT Analysis
Table 143. Cerulean Pharma Nano-drug Product and Services
Table 144. Cerulean Pharma Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 145. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Navidea Biopharmaceuticals Nano-drug Major Business
Table 147. Navidea Biopharmaceuticals Nano-drug Total Revenue (USD Million) (2018-2019)
Table 148. Navidea Biopharmaceuticals SWOT Analysis
Table 149. Navidea Biopharmaceuticals Nano-drug Product and Services
Table 150. Navidea Biopharmaceuticals Nano-drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 151. Global Nano-drug Sales by Manufacturer (2018-2019) (K Doses)
Table 152. Global Nano-drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 153. Global Nano-drug Sales by Regions (2015-2020) (K Doses)
Table 154. Global Nano-drug Sales Market Share by Regions (2015-2020)
Table 155. Global Nano-drug Revenue by Regions (2015-2020) (USD Million)
Table 156. North America Nano-drug Sales by Countries (2015-2020) (K Doses)
Table 157. North America Nano-drug Sales Market Share by Countries (2015-2020)
Table 158. North America Nano-drug Revenue by Countries (2015-2020) (USD Million)
Table 159. North America Nano-drug Revenue Market Share by Countries (2015-2020)
Table 160. Europe Nano-drug Sales by Countries (2015-2020) (K Doses)
Table 161. Europe Nano-drug Sales Market Share by Countries (2015-2020)
Table 162. Europe Nano-drug Revenue by Countries (2015-2020) (USD Million)
Table 163. Asia-Pacific Nano-drug Sales by Regions (2015-2020) (K Doses)
Table 164. Asia-Pacific Nano-drug Sales Market Share by Regions (2015-2020)
Table 165. Asia-Pacific Nano-drug Revenue by Regions (2015-2020) (USD Million)
Table 166. South America Nano-drug Sales by Countries (2015-2020) (K Doses)
Table 167. South America Nano-drug Sales Market Share by Countries (2015-2020)
Table 168. South America Nano-drug Revenue by Countries (2015-2020) (USD Million)
Table 169. South America Nano-drug Revenue Market Share by Countries (2015-2020)
Table 170. Middle East & Africa Nano-drug Sales by Countries (2015-2020) (K Doses)
Table 171. Middle East & Africa Nano-drug Sales Market Share by Countries (2015-2020)
Table 172. Middle East & Africa Nano-drug Revenue by Countries (2015-2020) (USD Million)
Table 173. Middle East & Africa Nano-drug Revenue Market Share by Countries (2015-2020)
Table 174. Global Nano-drug Sales by Type (2015-2020) (K Doses)
Table 175. Global Nano-drug Sales Share by Type (2015-2020)
Table 176. Global Nano-drug Revenue by Type (2015-2020) (USD Million)
Table 177. Global Nano-drug Revenue Share by Type (2015-2020)
Table 178. Global Nano-drug Sales by Application (2015-2020) (K Doses)
Table 179. Global Nano-drug Sales Share by Application (2015-2020)
Table 180. Global Nano-drug Sales Forecast by Regions (2021-2025) (K Doses)
Table 181. Global Nano-drug Market Share Forecast by Regions (2021-2025)
Table 182. Global Nano-drug Sales Forecast by Type (2021-2025) (K Doses)
Table 183. Global Nano-drug Market Share Forecast by Type (2021-2025)
Table 184. Global Nano-drug Sales Forecast by Application (2021-2025)
Table 185. Global Nano-drug Market Share Forecast by Application (2021-2025)
Table 186. Direct Channel Pros & Cons
Table 187. Indirect Channel Pros & Cons
Table 188. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nano-drug Picture
Figure 2. Global Sales Market Share of Nano-drug by Type in 2019
Figure 3. Liposomes Picture
Figure 4. Polymeric Micelles Picture
Figure 5. Solid lipid Nanoparticles Picture
Figure 6. Microemulsion and Nanoemulsion Picture
Figure 7. Nanosuspension Picture
Figure 8. Nano-drug Sales Market Share by Application in 2018
Figure 9. Cancer and Tumors Picture
Figure 10. Autoimmune Disorders Picture
Figure 11. Global Nano-drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Nano-drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Nano-drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Nano-drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Nano-drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Nano-drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Nano-drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 37. Global Nano-drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Nano-drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Nano-drug Revenue Market Share by Regions in 2018
Figure 40. North America Nano-drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Nano-drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Nano-drug Sales and Growth Rate (2015-2020)
Figure 43. South America Nano-drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Nano-drug Sales and Growth Rate (2015-2020)
Figure 45. North America Nano-drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Nano-drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Nano-drug Sales Market Share by Countries in 2018
Figure 48. North America Nano-drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Nano-drug Revenue Market Share by Countries in 2018
Figure 50. United States Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Canada Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Mexico Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 53. Europe Nano-drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Nano-drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Nano-drug Revenue Market Share by Countries in 2019
Figure 56. Germany Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. UK Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. France Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Russia Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Italy Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. Asia-Pacific Nano-drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Nano-drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Nano-drug Revenue Market Share by Regions 2019
Figure 64. China Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Japan Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Korea Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. India Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. Southeast Asia Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 69. South America Nano-drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Nano-drug Sales Market Share by Countries in 2019
Figure 71. South America Nano-drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Argentina Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 74. Middle East and Africa Nano-drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Nano-drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Nano-drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Nano-drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Egypt Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Turkey Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. South Africa Nano-drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 82. Global Nano-drug Sales and Growth Rate (2021-2025) (K Doses)
Figure 83. Global Nano-drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Nano-drug Market Forecast (2021-2025) (K Doses)
Figure 85. Europe Sales Nano-drug Market Forecast (2021-2025) (K Doses)
Figure 86. Asia-Pacific Sales Nano-drug Market Forecast (2021-2025) (K Doses)
Figure 87. South America Sales Nano-drug Market Forecast (2021-2025) (K Doses)
Figure 88. Middle East & Africa Sales Nano-drug Market Forecast (2021-2025) (K Doses)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel